Dr. Sushil Patel
Board Member
Replimune Group, Inc. (REPL)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Sushil Patel
Dr. Sushil Patel is recorded as CEO and Board Member at Replimune Group, Inc. (REPL). Replimune Group, Inc. reported in an 8-K filed March 26, 2024 that Dr. Sushil Patel was appointed Class III director, effective April 1, 2024. Replimune Group, Inc. reported in an 8-K filed March 26, 2024 that Dr. Sushil Patel was appointed chief executive officer, effective April 1, 2024.
“Dr. Patel has been appointed to join the Company's Board of Directors (the "Board") to serve as a Class III director”
“Dr. Sushil Patel, the Company's current chief strategy officer, has been appointed as the Company's chief executive officer, effective as of April 1, 2024”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-04-01–present
-
Current
2024-04-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Replimune Group, Inc.
Other people whose current roles at this company are on record from its filings.
- Sushil Patel CEO, Board Member
- Dieter Weinand Chairman, Board Member
- Philip Astley-Sparke Chairman
- Emily Hill CFO
- Andrew Schwendenman Chief Accounting Officer
- Christy Oliger Board Member
- Joseph Slattery Board Member
- Kapil Dhingra Board Member
- Madhavan Balachandran Board Member
- Michael Goller Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.